Hart RG - Search Results

1

Serum potassium level and dietary potassium intake as risk factors for stroke.

Hart RG, Pearce LA; Stroke Prevention in Atrial Fibrillation Investigators. Hart RG, et al. Neurology. 2003 Jun 10;60(11):1869-70; author reply 1870. doi: 10.1212/wnl.60.11.1869. Neurology. 2003. PMID: 12796561 Clinical Trial. No abstract available.

2

Atrial fibrillation, stroke, and acute antithrombotic therapy: analysis of randomized clinical trials.

Hart RG, Palacio S, Pearce LA. Hart RG, et al. Stroke. 2002 Nov;33(11):2722-7. doi: 10.1161/01.str.0000035735.49388.4a. Stroke. 2002. PMID: 12411668 Review.

3

Lessons from the Stroke Prevention in Atrial Fibrillation trials.

Hart RG, Halperin JL, Pearce LA, Anderson DC, Kronmal RA, McBride R, Nasco E, Sherman DG, Talbert RL, Marler JR; Stroke Prevention in Atrial Fibrillation Investigators. Hart RG, et al. Ann Intern Med. 2003 May 20;138(10):831-8. doi: 10.7326/0003-4819-138-10-200305200-00011. Ann Intern Med. 2003. PMID: 12755555 Review.

4

Transient ischemic attacks in patients with atrial fibrillation: implications for secondary prevention: the European Atrial Fibrillation Trial and Stroke Prevention in Atrial Fibrillation III trial.

Hart RG, Pearce LA, Koudstaal PJ. Hart RG, et al. Stroke. 2004 Apr;35(4):948-51. doi: 10.1161/01.STR.0000120741.34866.1D. Epub 2004 Feb 26. Stroke. 2004. PMID: 14988571 Clinical Trial.

5

Current status of stroke risk stratification in patients with atrial fibrillation.

Hart RG, Pearce LA. Hart RG, et al. Stroke. 2009 Jul;40(7):2607-10. doi: 10.1161/STROKEAHA.109.549428. Epub 2009 May 21. Stroke. 2009. PMID: 19461020 Review. No abstract available.

6

Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors.

Conway DS, Pearce LA, Chin BS, Hart RG, Lip GY. Conway DS, et al. Among authors: hart rg. Circulation. 2002 Oct 8;106(15):1962-7. doi: 10.1161/01.cir.0000033220.97592.9a. Circulation. 2002. PMID: 12370220 Clinical Trial.

7

Adjusted-dose warfarin versus aspirin for preventing stroke in patients with atrial fibrillation.

Hart RG, Pearce LA, Aguilar MI. Hart RG, et al. Ann Intern Med. 2007 Oct 16;147(8):590-2. doi: 10.7326/0003-4819-147-8-200710160-00018. Ann Intern Med. 2007. PMID: 17938402 No abstract available.

8

Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.

Hart RG, Pearce LA, Aguilar MI. Hart RG, et al. Ann Intern Med. 2007 Jun 19;146(12):857-67. doi: 10.7326/0003-4819-146-12-200706190-00007. Ann Intern Med. 2007. PMID: 17577005

9

Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation.

Conway DS, Pearce LA, Chin BS, Hart RG, Lip GY. Conway DS, et al. Among authors: hart rg. Circulation. 2003 Jul 1;107(25):3141-5. doi: 10.1161/01.CIR.0000077912.12202.FC. Epub 2003 Jun 9. Circulation. 2003. PMID: 12796127 Clinical Trial.

10

Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin.

Gage BF, van Walraven C, Pearce L, Hart RG, Koudstaal PJ, Boode BS, Petersen P. Gage BF, et al. Among authors: hart rg. Circulation. 2004 Oct 19;110(16):2287-92. doi: 10.1161/01.CIR.0000145172.55640.93. Epub 2004 Oct 11. Circulation. 2004. PMID: 15477396

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

409 results

Search Page

Filters